Plasmas
Blood plasma is the liquid cell-free portion of human blood. In addition to many other substances, it also contains components for blood clotting, i.e. both the coagulation factors and their inhibitors.
Plasma for transfusion (Frozen Fresh Plasma (FFP)) can be obtained either from whole blood donations or using a mechanical procedure. An anticoagulant solution is always added during the collection of FFP. FFP is frozen to a temperature below -30°C as soon as possible after being obtained.
Name
|
Marketing Authorisation Holder
|
License Number
|
License Date
|
Further Information
|
LyoPlas P
|
DRK-Blutspendedienst West gGmbH der Landesverbände Nordrhein, Westfalen-Lippe, Rheinland-Pfalz und Saarland - Zentrum Hagen
|
PEI.H.04493.01.1 |
08.02.2012 |
PharmNet.Bund
|
Gefrorenes Frischplasma UK S-H (Apherese)
|
Universitätsklinikum Schleswig-Holstein, Lübeck
|
PEI.H.04497.01.1 |
20.09.2010 |
PharmNet.Bund
|
Gefrorenes pathogenreduziertes Apheresefrischplasma Th-J
|
Universitätsklinikum Jena
|
PEI.H.11468.01.1 |
26.01.2011 |
PharmNet.Bund
|
Gefrorenes Plasmapherese-Frischplasma PR, HAEMA
|
Haema AG, Leipzig
|
PEI.H.11543.01.1 |
18.03.2013 |
PharmNet.Bund
|
Gefrorenes Frischplasma HDZ NRW (mit CPD)
|
Herz- und Diabeteszentrum NRW, Bad Oeynhausen
|
PEI.H.11792.01.1 |
26.07.2016 |
PharmNet.Bund
|
Gefrorenes Frischplasma (HDZ NRW), mit CPD
|
Herz- und Diabeteszentrum NRW, Bad Oeynhausen
|
PEI.H.11846.01.1 |
26.07.2016 |
PharmNet.Bund
|
Leukozytendepletiertes Gefrorenes Frischplasma CPD (UKW)
|
Universitätsklinikum Würzburg Anstalt des Öffentlichen Rechts
|
PEI.H.11908.01.1 |
03.04.2020 |
PharmNet.Bund
|
Gefrorenes Human-Frischplasma CPD BSD/BRK
|
Blutspendedienst des Bayerischen Roten Kreuzes gGmbH, München
|
PEI.H.11957.01.1 |
15.01.2021 |
|
Quarantäneplasma aus Apherese-KL, leukozytendepletiert
|
Universitätsklinikum Köln (AöR)
|
PEI.H.12052.01.1 |
21.06.2022 |
PharmNet.Bund
|
Quarantäneplasma aus Plasmapherese-KL
|
Universitätsklinikum Köln (AöR)
|
PEI.H.12053.01.1 |
11.07.2022 |
|
Gefrorenes Apheresefrischplasma Th-J quarantänegelagert, leukozytendepletiert
|
Institut für klinische Transfusionsmedizin Jena gGmbH
|
PEI.H.12114.01.1 |
16.11.2021 |
PharmNet.Bund
|
Disclaimer
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 519 in BAnz AT 26.07.2024 B6.
Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.